David ConnellIn this week’s Psychedelic news roundup, we discuss two new African psilocybe species, detail advancements in synthetic psychedelics, a rapid shift in American interest in DMT, and more.
New Hallucinogenic Mushrooms Discovered in Southern Africa: A Leap in Psychedelic Research
As reported by Newsweek, a groundbreaking discovery has expanded our understanding of psychedelic flora. Scientists have identified two new species of hallucinogenic mushrooms in southern Africa, Psilocybe ingeli and Psilocybe maluti. This finding, detailed in a recent publication in Mycologia, highlights the region’s rich biodiversity and the potential for new research into the psychoactive properties of these fungi.
Key Discoveries:
Research and Implications:
The article’s authors believe this discovery enhances our knowledge of unique biological systems and highlights the critical role of regional biodiversity in unraveling global ecological patterns and the therapeutic potential of psychedelic compounds.(1)
Massachusetts to Vote on Psychedelics Legalization in November
As reported by Marijuana Moment, Massachusetts voters are set to make a significant decision this November on whether to legalize certain psychedelic substances. The measure, aimed at addressing a range of mental health conditions, will appear on the ballot after successful petitioning by the campaign group Massachusetts for Mental Health Options (MMHO). Secretary of the Commonwealth William F. Galvin confirmed that activists had gathered sufficient signatures to advance the proposal.
Keep Up with Psychedelic Trends
Don’t miss the latest psychedelic news, events, companies, and more.
We respect and protect your privacy. By subscribing your info will be subject to our privacy policy. Unsubscribe easily at any time
Key Points of the Initiative:
The proposal has faced skepticism despite the enthusiasm from advocates like Emily Oneschuk, a veteran and the nation’s first female Navy Seals candidate, who emphasized the potential benefits for veterans and other residents. A recent report from the legislature’s Special Joint Committee on Ballot Initiatives recommended against the measure, questioning the safety and benefits of widespread recreational legalization. The committee expressed concerns about creating dual systems for psychedelic use—one through regulated service centers and another through broader decriminalization.
As Massachusetts prepares for the November vote, the outcome could pave the way for significant changes in how psychedelics are accessed and used, potentially influencing broader national discussions on drug policy reform. The decision remains contentious, reflecting deep divides on the best approaches to integrate such substances into society legally and safely.(2)
Could Synthetic Psilocybin be an Effective Depression Treatment?
Forbes details a new psychedelic tool for the treatment of certain types of depression. The battle against treatment-resistant depression (TRD) has long been a tough one, with many individuals struggling to find relief through traditional methods such as antidepressants, talk therapy, and alternative treatments. However, recent advancements in synthetic psychedelic research may hold a solution if proven effective.
About COMP360 Synthetic Psilocybin:
Understanding the Treatment:
Current Research and Safety Measures:
By focusing on the brain’s adaptability and addressing depression at a neurological level, researchers are optimistic about providing new hope for those who have found little relief with existing treatments.(3)
DMT Tops American Psychedelic Curiosity Over Shrooms and Marijuana
Phoenix New Times covers the rise of a surprising psychedelic darling capturing America’s imagination. Despite the legality of marijuana in many states, including Arizona since 2020, and the growing interest in psilocybin mushrooms with ongoing studies and decriminalization efforts, Americans are most curious about another psychedelic: DMT (dimethyltryptamine). This compound, which is also present in the South American brew ayahuasca (made from the Banisteriopsis caapi vine boiled with the leaves of the Psychotria viridis shrub), is now the leading subject of psychedelic-related searches in the U.S., according to a new study by SporesMD.
Key Insights:
This surge in interest likely stems from DMT’s unique psychedelic profile. Some research suggests DMT is a naturally occurring substance in several plant species and possibly the human body. Its effects are profound, offering a rapid onset of hallucinations filled with vibrant colors and geometric patterns, lasting about 15 to 30 minutes when smoked or vaped—much shorter than LSD or psilocybin experiences. These characteristics contribute to its mystique and the growing intrigue around its therapeutic potential and spiritual significance, drawing attention beyond traditional psychedelic communities to a broader audience seeking profound, time-efficient transformative experiences.(4)
Keep Up with Psychedelic Trends
Don’t miss the latest psychedelic news, events, companies, and more.
We respect and protect your privacy. By subscribing your info will be subject to our privacy policy. Unsubscribe easily at any time
Sources
1. Science, A. G., & Reporter, H. (2024, July 8). Scientists discover two new species of hallucinogenic mushroom. Newsweek. https://www.newsweek.com/scientists-discover-two-new-species-hallucinogenic-mushroom-1922228
2. Jaeger, K. (2024, July 11). Massachusetts Voters Will Decide On Psychedelics Legalization Initiative On November Ballot, State Announces. Marijuana Moment. https://www.marijuanamoment.net/massachusetts-voters-will-decide-on-psychedelics-legalization-initiative-on-november-ballot-state-announces/
3. Travers, M. (n.d.). A Synthetic Psychedelic Is Making Waves In Stubborn Depression Treatment—Here’s What You Need To Know. Forbes. Retrieved July 11, 2024, from https://www.forbes.com/sites/traversmark/2024/07/08/a-synthetic-psychedelic-is-making-waves-in-stubborn-depression-treatment-heres-what-you-need-to-know/
4. Buchanan, Z. (n.d.). Move over, shrooms: Americans are most curious about this psychedelic. Phoenix New Times. Retrieved July 11, 2024, from https://www.phoenixnewtimes.com/marijuana/americans-more-curious-about-dmt-than-other-psychedelic-drugs-study-19419042
This material is not intended as a replacement or substitute for any legal or medical advice. Always consult a medical professional about your health needs. Psychedelics are widely illegal in the United States, and readers should always be informed about local, state, and federal regulations regarding psychedelics or other drugs.
